According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -6,14ย โฌ. In 2024 the company made an earnings per share (EPS) of -0,04313ย โฌ a decrease over its 2023 EPS that were of 2,49ย โฌ.
Year | EPS | Change |
---|---|---|
2025 (TTM) | -6,65ย โฌ | 15320.57% |
2024 | -0,04313ย โฌ | -101.73% |
2023 | 2,49ย โฌ | -245.96% |
2022 | -1,71ย โฌ | -157.23% |
2021 | 2,98ย โฌ | -2571.43% |
2020 | -0,12ย โฌ | -100.46% |
2019 | 26,41ย โฌ | 353.48% |
2018 | 5,82ย โฌ | 1025% |
2017 | 0,52ย โฌ | -700% |
2016 | -0,08627ย โฌ | -100.87% |
2015 | 9,97ย โฌ | 1859.32% |
2014 | 0,51ย โฌ | 5.36% |
2013 | 0,48ย โฌ | 8.0704505322479E+18% |
2012 | 0,0000000000ย โฌ |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
![]() Amgen AMGN | 9,53ย โฌ | -255.20% | ๐บ๐ธ USA |
![]() Spectrum Pharmaceuticals
SPPI | -0,31ย โฌ | -94.94% | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | 1,35ย โฌ | -121.91% | ๐ฌ๐ง UK |
![]() Merck MRK | 5,95ย โฌ | -196.87% | ๐บ๐ธ USA |
![]() Pfizer PFE | 1,20ย โฌ | -119.52% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | 10,66ย โฌ | -273.54% | ๐บ๐ธ USA |
![]() Bristol-Myers Squibb BMY | 2,31ย โฌ | -137.64% | ๐บ๐ธ USA |
![]() Baxter BAX | -0,02588ย โฌ | -99.58% | ๐บ๐ธ USA |
![]() Johnson & Johnson JNJ | 7,82ย โฌ | -227.35% | ๐บ๐ธ USA |